Home Healthcare Healthcare Services Compounding Pharmacies Market

Compounding Pharmacies Market Size, Share & Trends Analysis Report By Dosage Forms (Solid Oral Preparations, Liquid Preparations, Topical, Ophthalmic, Nasal, Others), By Therapeutic Area (Hormone Replacement Therapy, Pain Management, Dermatology applications, Specialty drugs, Nutritional supplements, Others), By Compounding Type (Pharmaceutical ingredient alteration (PIA), Pharmaceutical application alteration (PAA), Currently unavailable pharmaceutical manufacturing (CUPM), Pharmaceutical dosage alteration (PDA), Specialized animal pharmaceutical manufacturing (SAPM)), By End-User (Adult, Pediatric, Geriatric, Veterinary) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Compounding Pharmacies Market, By Dosage Forms 2022-2034 (USD MILLION/ Units)
    1. Solid Oral Preparations
    2. Liquid Preparations
    3. Topical
    4. Ophthalmic
    5. Nasal
    6. Others
  2. Compounding Pharmacies Market, By Therapeutic Area 2022-2034 (USD MILLION/ Units)
    1. Hormone Replacement Therapy
    2. Pain Management
    3. Dermatology applications
    4. Specialty drugs
    5. Nutritional supplements
    6. Others
  3. Compounding Pharmacies Market, By Compounding Type 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical ingredient alteration (PIA)
    2. Pharmaceutical application alteration (PAA)
    3. Currently unavailable pharmaceutical manufacturing (CUPM)
    4. Pharmaceutical dosage alteration (PDA)
    5. Specialized animal pharmaceutical manufacturing (SAPM)
  4. Compounding Pharmacies Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Adult
    2. Pediatric
    3. Geriatric
    4. Veterinary
  5. Regional Compounding Pharmacies Market
    1. North America
      1. North America Compounding Pharmacies Market By Dosage Forms 2022-2034 (USD MILLION/ Units)
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
      2. North America Compounding Pharmacies Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Hormone Replacement Therapy
        2. Pain Management
        3. Dermatology applications
        4. Specialty drugs
        5. Nutritional supplements
        6. Others
      3. North America Compounding Pharmacies Market By Compounding Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical ingredient alteration (PIA)
        2. Pharmaceutical application alteration (PAA)
        3. Currently unavailable pharmaceutical manufacturing (CUPM)
        4. Pharmaceutical dosage alteration (PDA)
        5. Specialized animal pharmaceutical manufacturing (SAPM)
      4. North America Compounding Pharmacies Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Adult
        2. Pediatric
        3. Geriatric
        4. Veterinary
      5. U.S.
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      6. Canada
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
    2. Europe
      1. Europe Compounding Pharmacies Market By Dosage Forms 2022-2034 (USD MILLION/ Units)
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
      2. Europe Compounding Pharmacies Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Hormone Replacement Therapy
        2. Pain Management
        3. Dermatology applications
        4. Specialty drugs
        5. Nutritional supplements
        6. Others
      3. Europe Compounding Pharmacies Market By Compounding Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical ingredient alteration (PIA)
        2. Pharmaceutical application alteration (PAA)
        3. Currently unavailable pharmaceutical manufacturing (CUPM)
        4. Pharmaceutical dosage alteration (PDA)
        5. Specialized animal pharmaceutical manufacturing (SAPM)
      4. Europe Compounding Pharmacies Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Adult
        2. Pediatric
        3. Geriatric
        4. Veterinary
      5. U.K.
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      6. Germany
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      7. France
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      8. Spain
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      9. Italy
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      10. Russia
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      11. Nordic
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      12. Benelux
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      13. Rest of Europe
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
    3. APAC
      1. APAC Compounding Pharmacies Market By Dosage Forms 2022-2034 (USD MILLION/ Units)
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
      2. APAC Compounding Pharmacies Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Hormone Replacement Therapy
        2. Pain Management
        3. Dermatology applications
        4. Specialty drugs
        5. Nutritional supplements
        6. Others
      3. APAC Compounding Pharmacies Market By Compounding Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical ingredient alteration (PIA)
        2. Pharmaceutical application alteration (PAA)
        3. Currently unavailable pharmaceutical manufacturing (CUPM)
        4. Pharmaceutical dosage alteration (PDA)
        5. Specialized animal pharmaceutical manufacturing (SAPM)
      4. APAC Compounding Pharmacies Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Adult
        2. Pediatric
        3. Geriatric
        4. Veterinary
      5. China
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      6. Korea
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      7. Japan
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      8. India
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      9. Australia
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      10. Singapore
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      11. Taiwan
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      12. South East Asia
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      13. Rest of Asia-Pacific
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
    4. Middle East and Africa
      1. Middle East and Africa Compounding Pharmacies Market By Dosage Forms 2022-2034 (USD MILLION/ Units)
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
      2. Middle East and Africa Compounding Pharmacies Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Hormone Replacement Therapy
        2. Pain Management
        3. Dermatology applications
        4. Specialty drugs
        5. Nutritional supplements
        6. Others
      3. Middle East and Africa Compounding Pharmacies Market By Compounding Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical ingredient alteration (PIA)
        2. Pharmaceutical application alteration (PAA)
        3. Currently unavailable pharmaceutical manufacturing (CUPM)
        4. Pharmaceutical dosage alteration (PDA)
        5. Specialized animal pharmaceutical manufacturing (SAPM)
      4. Middle East and Africa Compounding Pharmacies Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Adult
        2. Pediatric
        3. Geriatric
        4. Veterinary
      5. UAE
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      6. Turkey
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      7. Saudi Arabia
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      8. South Africa
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      9. Egypt
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      10. Nigeria
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      11. Rest of MEA
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
    5. LATAM
      1. LATAM Compounding Pharmacies Market By Dosage Forms 2022-2034 (USD MILLION/ Units)
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
      2. LATAM Compounding Pharmacies Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Hormone Replacement Therapy
        2. Pain Management
        3. Dermatology applications
        4. Specialty drugs
        5. Nutritional supplements
        6. Others
      3. LATAM Compounding Pharmacies Market By Compounding Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical ingredient alteration (PIA)
        2. Pharmaceutical application alteration (PAA)
        3. Currently unavailable pharmaceutical manufacturing (CUPM)
        4. Pharmaceutical dosage alteration (PDA)
        5. Specialized animal pharmaceutical manufacturing (SAPM)
      4. LATAM Compounding Pharmacies Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Adult
        2. Pediatric
        3. Geriatric
        4. Veterinary
      5. Brazil
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      6. Mexico
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      7. Argentina
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      8. Chile
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      9. Colombia
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
      10. Rest of LATAM
        1. Solid Oral Preparations
        2. Liquid Preparations
        3. Topical
        4. Ophthalmic
        5. Nasal
        6. Others
        7. Hormone Replacement Therapy
        8. Pain Management
        9. Dermatology applications
        10. Specialty drugs
        11. Nutritional supplements
        12. Others
        13. Pharmaceutical ingredient alteration (PIA)
        14. Pharmaceutical application alteration (PAA)
        15. Currently unavailable pharmaceutical manufacturing (CUPM)
        16. Pharmaceutical dosage alteration (PDA)
        17. Specialized animal pharmaceutical manufacturing (SAPM)
        18. Adult
        19. Pediatric
        20. Geriatric
        21. Veterinary
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.